Health
Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults – Medical Xpress
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune re…
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England Journal of Medicine describes the findings from the study, which was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19 disease.
The experimental vaccine,…
-
General22 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News23 hours agoExclusion zone declared as bushfire sparks major emergency response near Brisbane
-
Noosa News23 hours agoMan arrested after gaining ‘unauthorised’ access to Amberley RAAF base
-
Noosa News22 hours agoBroncos and Roosters set for ‘Queensland versus NSW rivalry’ in NRLW grand final